Study of Tipifarnib as Postconsolidation Therapy for Acute Myeloid Leukemia in Patients 60 Years and Older
Clinical trial NCT00048503 · COMPLETED
Trial details
- NCT number
- NCT00048503
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2002-06-01
- Enrollment
- 88
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.